MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q4
hinzugefügt 03.03.2026
Agilent Technologies Langfristige Verbindlichkeiten 2011-2026 | A
Langfristige Verbindlichkeiten Jährlich Agilent Technologies
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 3.29 B | 2.62 B | 2.8 B | 2.33 B | 2.61 B | 2.33 B | 3.83 B | 3.8 B | 3.46 B | 2.9 B |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3.83 B | 2.33 B | 3 B |
Langfristige Verbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Langfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
23.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Aspira Women's Health
AWH
|
3.49 M | - | -6.19 % | $ 10.5 M |  USA |
 |
Biocept
BIOC
|
11.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
16.4 M | $ 1.16 | -1.69 % | $ 6.32 M | USA |
 |
Chembio Diagnostics
CEMI
|
24.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
865 K | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
17.9 M | $ 16.69 | -6.86 % | $ 889 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
7.74 M | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
527 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Enzo Biochem
ENZ
|
4.6 M | - | -8.98 % | $ 14.8 K | USA |
 |
Burning Rock Biotech Limited
BNR
|
61.1 M | $ 16.25 | 0.06 % | $ 175 M |  China |
 |
Exact Sciences Corporation
EXAS
|
981 M | - | - | $ 19.8 B | USA |
 |
Co-Diagnostics
CODX
|
574 K | $ 4.4 | 101.83 % | $ 5.85 M | USA |
 |
Accelerate Diagnostics
AXDX
|
134 M | - | -61.36 % | $ 2.46 M | USA |
 |
Castle Biosciences
CSTL
|
2.76 M | $ 23.43 | -6.99 % | $ 651 M | USA |
 |
Global Cord Blood Corporation
CO
|
2.53 B | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
131 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
559 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
48.5 M | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
2.35 B | $ 175.55 | 0.27 % | $ 8.7 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.43 B | - | - | $ 10.7 B | USA |
 |
Danaher Corporation
DHR
|
26.9 B | $ 192.99 | -1.63 % | $ 138 B | USA |
 |
Heska Corporation
HSKA
|
57.9 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
4.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
Interpace Biosciences
IDXG
|
10 M | $ 2.3 | 16.02 % | $ 10.2 M | USA |
 |
Illumina
ILMN
|
2.04 B | $ 123.67 | -3.38 % | $ 19.7 B | USA |
 |
Fulgent Genetics
FLGT
|
2.26 M | $ 15.02 | -5.12 % | $ 454 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
8.08 B | $ 28.13 | 0.29 % | $ 20 B |  Niderland |
 |
Guardant Health
GH
|
91.4 M | $ 87.17 | -6.11 % | $ 10.9 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.99 B | - | - | $ 10.6 B | Niderland |
 |
Anixa Biosciences
ANIX
|
4.17 M | $ 2.74 | 0.37 % | $ 88.9 K | USA |
 |
Biomerica
BMRA
|
1.57 M | $ 2.2 | 2.33 % | $ 5.05 M | USA |
 |
ICON Public Limited Company
ICLR
|
461 M | $ 106.7 | 0.15 % | $ 8.8 B |  Irlanda |
 |
Check-Cap Ltd.
CHEK
|
16 K | - | - | $ 9.42 M |  Israel |
 |
Laboratory Corporation of America Holdings
LH
|
7.82 B | $ 273.26 | -0.53 % | $ 22.7 B | USA |
 |
Celcuity
CELC
|
69.2 K | $ 124.64 | 6.58 % | $ 5.83 B | USA |
 |
Medpace Holdings
MEDP
|
73.8 M | $ 501.5 | -3.68 % | $ 14.5 B | USA |
 |
Lantheus Holdings
LNTH
|
225 M | $ 81.43 | 1.75 % | $ 5.5 B | USA |
 |
Motus GI Holdings
MOTS
|
2.16 M | - | -34.28 % | $ 263 K | Israel |
 |
Myriad Genetics
MYGN
|
107 M | $ 4.44 | -6.92 % | $ 411 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.17 B | $ 197.82 | -0.5 % | $ 22 B | USA |
 |
NeoGenomics
NEO
|
435 M | $ 7.94 | -3.38 % | $ 1.02 B | USA |
 |
Neogen Corporation
NEOG
|
19.6 M | $ 10.04 | -2.95 % | $ 2.18 B | USA |
 |
ENDRA Life Sciences
NDRA
|
843 K | $ 5.31 | 2.71 % | $ 4.18 M | USA |
 |
National Research Corporation
NRC
|
39.6 M | $ 17.05 | -1.22 % | $ 382 M | USA |
 |
Natera
NTRA
|
124 M | $ 203.0 | -3.71 % | $ 20 B | USA |
 |
Invitae Corporation
NVTA
|
320 M | - | - | $ 21.2 M | USA |
 |
Organovo Holdings
ONVO
|
588 K | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
21.2 M | - | -16.95 % | $ 1.54 M | USA |